Julie Jordan - Chief Medical Officer at Neurogene Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Issuer Symbol
NGNE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Julie Jordan since 31 Jan 2025

Holdings reported by Julie Jordan for Neurogene Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 8,400 $142,296 $16.94 26 Mar 2025 Direct
Employee Stock Option (Right to buy) 50,300 26 Mar 2025 Direct Common Stock

Transactions reported by Julie Jordan for Neurogene Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.